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Abstract
Objective: We sought to determine if differences in the distribution and characteristics of adipose tissue between South
Asians and white Caucasians account for differences in risk factors for cardiovascular disease.
Research Design and Methods: We recruited 108 healthy South Asians (36.8 years) and white Caucasians (34.2 years) within
three BMI strata. Body composition, adipocyte size, abdominal fat area, and hepatic adiposity were assessed and related to
fasting glucose, insulin, lipids and adiponectin.
Results: After adjustment for age, sex, and BMI, South Asians compared to white Caucasians had higher ln fasting insulin
(mean difference (md): 0.44; 95% CI: 0.20–0.69), lower HDL cholesterol (md: 20.13; 95% CI:20.26 to 20.01), and lower
adiponectin (md: 22.38; 95% CI: 23.59 to 21.17). South Asians also had more body fat (md: 2.69; 95% CI: 0.70 to 4.69),
lower lean muscle mass (md: 23.25; 95%CI: 25.35 to 21.14), increased waist to hip ratio (md: 0.03; 95% CI: 0.01–0.05), less
superficial subcutaneous abdominal adipose tissue (md: 22.94; 95% CI: 25.56 to20.32), more deep/visceral to superficial
adipose tissue ratio (md 0.34; 95% CI: 0.02 to 0.65), and more liver fat (md: 7.43%; 95% CI: 2.30 to 12.55%). Adipocyte area
was increased in South Asians compared to white Caucasians (md: 64.26; 95% CI: 24.3 to 104.1) units
2. Adjustment for
adipocyte area attenuated the ethnic differences in insulin (md: 0.22; 95% CI: 20.07 to 0.51), HDL (md: 20.01; 95% CI: 20.16
to 0.13) and adiponectin (md: 21.11; 95% CI: 22.61 to 0.39). Adjustment for differences in adipocyte area and fat
distribution attenuated the ethnic difference in liver fat (md: 5.19; 95% CI: 0.31 to 10.06).
Conclusion: South Asians have an increased adipocyte area compared to white Caucasians. This difference accounts for the
ethnic differences in insulin, HDL cholesterol, adiponectin, and ectopic fat deposition in the liver.
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Introduction
South Asians (people who originate from the Indian subconti-
nent) are more likely to develop type 2 diabetes and myocardial
infarction (MI) at younger ages compared to white Caucasians of
European origin [1–3]. Recent evidence suggests that South
Asians develop changes in metabolic risk factors for cardiovascular
disease (CVD), such as glucose, insulin, lipid levels and adipokines
at significantly lower body mass indices than white Caucasians [4].
This may be due to a higher total body fat, and higher ectopic fat
deposition in the abdomen, liver and elsewhere. This ectopic fat
distribution may occur as a result of a diminished storage capacity
of superficial subcutaneous adipose tissue leading to an overflow of
fatty acids to ectopic sites where it may affect structure and/or
function [5–7]. We investigated whether differences in the amount
of total fat, its distribution and adipocyte characteristics can
account for differences in metabolic risk factors for CVD (i.e.
glucose, insulin, lipids, adiponectin) in South Asians compared to
white Caucasians.
Methods
This study was approved by the Hamilton Health Sciences/
Faculty of Health Sciences Research Ethics Board on July 25,
2005 and written informed consent was obtained from each
participant.
Recruitment
Men and women of South Asian origin (defined as parents and
grandparents who originated from India, Pakistan, Sri Lanka, or
Bangladesh) and white Caucasians (ancestors originated from
Europe) were consecutively recruited into one of three BMI strata:
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2, 26–29 kg/m
2, $30 kg/m
2, and matched on sex and
age (+/25 years). Individuals with established cardiovascular
disease and/or with previously diagnosed type 2 diabetes were
excluded. Participants were recruited by public advertisements in
temples, hospitals, on the university campus, and by letters mailed
to homes in geographic areas where high concentrations of South
Asians lived. Potential participants were assessed for eligibility over
the telephone, and if eligible and agreeable to the study protocol,
they were invited to complete two consecutive visits.
Measurements and Methods
Biochemical Measurements. Blood samples were taken
from all participants after a 12 hour fast. Total serum cholesterol
and glucose were measured using enzymatic methods [8,9]. Serum
LDL cholesterol was calculated using the Friedewald formula [10],
and HDL cholesterol was measured using a homogenous enzymatic
colorimetric assay (ROCHE/Hitachi Modular Package Insert).
Triglycerides were measured using the enzymatic colorimetric assay
on the ROCHE/Hitachi Modular instrument and reagent kit.
Insulin was measured on the Roche Elecsys R 2010 immunoassay
analyzer using an electrochemiluminescence immunoassay (Roche
Diagnostics GmbH, Indianapolis, Indiana, USA). Serum CRP was
measured on the Roche Hitachi 917 using the Tina-quant R CRP
high sensitive immunoturbidimetric assay. Analysis of adiponectin
was performed using a manual qualitative sandwich immunoassay
technique (ELISHA) kit manufactured by R&D Systems Inc
(Minneapolis, Minnesota, USA). Basal insulin resistance was
calculated using the previously validated homeostatic model
assessment index (HOMA-IR) model [11].
Body Composition Assessment. Height and weight, and
waist and hip circumference were measured using standard
methods [2]. Total body fat was measured by Dual-energy X-
ray absorptiometry (DXA) after an overnight fast [12]. Detailed
descriptions of the methods used to assess body composition,
abdominal and liver adipose tissue measurements, and adipose
and muscle biopsies are found in the study protocol posted on-line
[12].
Abdominal Adipose Tissue Measurements. Abdominal
visceral and subcutaneous fat area were assessed by magnetic
resonance imaging (MRI) performed on a 1.5T whole body MR
system (Siemens Symphony). After 3-plane localizer image
acquisition, breath-hold axial T1-weighted images at the level of
mid-L4 (TR 400 ms, TE 13 ms) were acquired. The volumes of
subcutaneous (superficial distinguished from deep subcutaneous
tissue where possible) and visceral fat were determined by manual
tracing of the areas of fat at the laboratory of Dr. Scott Lear.
Intrahepatic fat was assessed using localized single voxel (1–2 cc
volume) proton spectra using a phased-array body coil for
radiofrequency signal receiving [12].
Adipose Tissue Biopsy. Subcutaneous fat biopsies were
collected from the superficial subcutaneous fat ,2–3 cm below
skin in the periumbilical region using a Bergstrom needle modified
Table 1. Baseline characteristics of participants.
Men * Women * Overall {
South Asian European South Asian European South Asian European
P-
value
Number/group 32 21 24 31 56 52
Age (years) 36.061.7 33.162.1 37.962.0 34.861.8 36.861.3 34.261.4
Current Smoking (#) 2 (6.3%) 3 (14.3%) 0 (0%) 1 (3.2%) 2 (3.6%) 4 (7.7%)
Physical Activity score
(1=low,2=mod,3=high)
1.560.1 1.960.2 1.360.1 1.460.1 1.460.1 1.660.1
Height (cm) 174.261.2 177.361.5 162.261.3 164.261.1 167.7160.86 170.9560.90 0.01
Weight (kg) 83.162.2 87.962.7 67.863.0 1 77.662.7 1 77.9060.84 80.2760.87 0.06
Body Mass Index (kg/m
2) 27.260.7 27.760.9 25.761.2 1 29.161.0 1
Waist Circumference (cm) 96.961.9 97.662.4 87.362.7 90.662.3 94.1460.82 92.0060.86 0.08
Hip Circumference (cm) 105.461.6 106.562.0 103.862.3 1 112.362.0 1 106.5960.77 107.9360.80 0.24
Waist-to-Hip Ratio 0.9260.01 0.9260.01 0.8460.01 1 0.8060.01 1 0.8860.01 0.8560.01 0.007
Systolic Blood Pressure (mm Hg) 113.461.3 114.061.6 110.462.1 110.561.8 112.3661.15 111.5961.19 0.65
Diastolic Blood Pressure (mm Hg) 75.861.3 75.061.6 74.061.5 73.561.3 75.2260.96 73.8661.00 0.34
Glucose (mmol/L) 5.1160.08 5.0360.10 4.9160.10 4.8560.09 5.0360.06 4.9260.07 0.24
Ln Insulin (pmol/L) 4.2360.11 || 3.8160.13 || 3.9960.19 3.9860.14 4.2660.09 3.8160.08 0.0006
HOMA-IR index 2.8760.32 1.9460.39 2.5360.96 2.5460.71 3.0760.42 2.0060.40 0.08
HDL (mmol/L) 1.2460.06 1.1860.07 1.2760.07 1 1.5060.06 1 1.2460.04 1.3860.04 0.03
Triglycerides (mmol/L) 1.5760.19 1.7160.23 1.3160.18 1.1160.15 1.4860.13 1.3360.13 0.44
Total cholesterol/HDL ratio 3.9660.24 4.6060.30 3.8060.22 3.3060.19 3.9060.17 3.8160.17 0.69
Adiponectin (ug/mL) 4.3060.44 || 5.7960.54 || 6.7760.75 1 9.3860.66 1 5.4560.41 7.8360.43 0.0002
hs-CRP (mg/L) 1.6660.33 2.2260.41 1.5360.95 3.1460.70 2.1160.37 2.3160.36 0.70
* Means (6 SE) are adjusted for age,
{ Means (6 SE) are adjusted for age, sex, BMI { p,0.05 comparing South Asians to Europeans overall,
1 p,0.05 comparing South Asian women to European women,
|| p,0.05 comparing South Asian men to European men; Physical activity score derived from the SHARE activity index (14).
doi:10.1371/journal.pone.0022112.t001
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(,10 mg) were preserved in 40% formalin for subsequent
embedding in paraffin, cutting and staining for macrophages
with a Mac3 antibody. 50–60 mg of fresh adipose tissue were
conserved in 3 mL OsO4 +2.2 mL collidine HCl digested, stained
with hemotyxylin and eosin and aliquoted and placed onto a glass
slide. From these slides, digital images (20/person) were created.
Adipocyte Area Measurement. Adipocyte area and maxi-
mum diameter were determined using a software program
utilizing the NIH’s open-share Image J Software program [13].
The macros were set up to analyze the digested, fixed onto slides,
stained (with osmium, hematoxylin and eosin staining) and
photographed approximately 50,000 adipocytes from 79 partici-
pants. The application was for the photographed slides of the
adipocytes. The macros developed determined which cells to
include in the calculations of size (as they had to be above a certain
level of circularity and size so that no pre-adipocytes or other cell
types would be included in the calculations of size), and to
calculate the area, width, height, Feret’s diameter, minimum
Feret’s diameter, circularity, perimeter for each adipocyte assigned
to each subject.
Skeletal Muscle Measurements. Habitual physical activity
was assessed with validated physical activity questionnaires [14],
and a direct assessment of fitness and strength was made [12].
Subjects were exercised for 15 minutes, the first 5 minutes at a
workload of 15 Watts and the next 10 minutes at a workload of
50 Watts. Cardiovascular fitness (VO2max) was determined at
rest, at 5 minutes into exercise, after 15 minutes of exercise, and 5
minutes after stopping exercise in all subjects using an
electronically braked cycle ergometer, and computerized open-
circuit gas collection system. Muscle biopsies were taken from the
vastus lateralis using a Bergstrom needle modified with suction,
under local anaesthesia. Approximately 15 mg of tissue was
dissected free and immediately placed into 2% glutaraldehyde for
transmission electron microscopy (TEM) to quantify lipid droplet
characteristics as previously described [15]. The total number of
lipids, mean lipid area, percent lipid area density, and the
percentage of lipids touching mitochondria were determined
using imaging software (Image Pro Plus, Media Cybernetics,
Silver Springs, MD). The method and reliability of the IMCL
calculation has been established by the Tarnopolsky lab and
published previously [15]. All biochemical, body fat, adipocyte and
muscle analyses were performed by readers who were blinded to participants
ethnicity.
Statistical
Power. We aimed to recruit 60 subjects per ethnic group
distributed equally in 3 BMI strata and approximately balanced by
age and sex. We estimated this sample size would provide more
than 80% power to detect an absolute difference comparing South
Asians to white Caucasians in total body fat measured by DXA of
3.7%, and an absolute difference in the visceral to superficial
adipose tissue ratio as low as 0.26. We recruited 108 subjects and
while our power was maintained for the primary outcomes, our
power was lower to detect sex differences, and for multivariate
regression modelling [16].
Table 2. Adipose and lean tissue characteristics of participants.
Men* Women* Overall{
South Asian European South Asian European South Asian European
Number/group 32 21 24 31 56 52
Total Tissue Mass (kg) 79.461.2 82.961.5 68.461.0 70.061.0 74.160.8 { 76.660.9 {
Percent Body Fat by DXA 28.660.9 27.261.2 43.060.9 1 38.960.9 1 35.460.7{ 32.760.7{
Subcutaneous (SC) Fat Area by MRI (cm
2) 238.5610.7 239.4614.6 282.8614.4 282.8613.4 259.868.7 260.0610.0
Superficial SC Fat (cm
2) 100.564.9 107.066.0 139.0610.4 157.969.2 118.965.4 131.965.8
Deep SC Fat (cm
2) 154.868.9 145.5611.0 127.669.9 123.968.5 142.467.3 135.667.6
Visceral Fat Area by MRI (cm
2) 153.568.8 134.5612.1 97.367.3 95.666.8 126.866.1 117.567.0
Superficial SC % of Total Fat|| 25.661.0 27.861.2 38.661.6 42.261.4 31.760.9 { 34.660.9 {
Deep SC +Visceral Fat/Superficial SC Fat Ratio 3.1560.16 2.6860.19 1.7060.13 1.4660.11 2.4760.11 { 2.1460.11{
Liver Fat (%) 10.862.0 4.762.6 9.462.9 1 0.262.7 1 9.961.7 { 2.561.9 {
Adipocyte Area (x100 units
2) 444.9616.5 " 383.8621.4 " 464.3623.8 1 391.1618.6 1 451.8613.5 { 387.7614.1 {
Adipocyte maximum diameter 256.465.2 " 237.366.8 " 264.067.7 1 239.266.0 1 259.064.4 { 238.464.5 {
Total Fat Free Mass (kg) 59.061.2 " 62.861.5 " 41.060.8 1 44.060.7 1 50.460.7 { 53.760.8 {
Total Body Lean Mass (kg) 55.961.1 " 59.661.4 " 38.560.7 1 41.460.7 1 47.660.7 { 50.860.8 {
IMCL Area Density (%)
Total 0.8660.08 0.9960.10 0.8160.15 1.0060.10 0.8360.08 1.0160.07
Subsarcolemmal 6.8360.67 6.2460.84 6.7761.21 6.9860.81 6.7660.64 6.7460.61
Intramyofibrillar 0.5260.06 0.6560.08 0.5260.13 0.7060.08 0.5260.06 0.6860.06
* Means (6 SE) are adjusted for age and BMI,
{ Means (6 SE) are adjusted for age, sex and BMI,
|| Total fat area refers to: superficial + deep+visceral fat by MRI,
{ p,0.05 comparing South Asians to Europeans overall,
1 p,0.05 comparing South Asian women to European women,
" p,0.05 comparing South Asian men to European men,
Note: There was no change in the IMCL change after adjustment for peak exercise capacity i.e. Vo2 max at 15 mins.
doi:10.1371/journal.pone.0022112.t002
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9.1.3 (Cary, N.C.). The distribution of all continuous variables was
examined, and log transformed to achieve normality if required.
Generalized Linear Models (PROC GLM) were used to make
comparisons between ethnic groups for metabolic parameters and
liver fat tertiles. Adjustments for age, sex, and BMI were made for
all ethnic comparisons, and additional covariates were added to a
maximum of 5 where indicated. These models provided the mean
differences between groups and their respective 95% confidence
intervals. We used the LSMEANS option to compute adjusted
means and standard errors.
Results
Baseline Characteristics
One hundred and eight participants were recruited from
Hamilton, Canada between November 10, 2005 and March 15,
2009. The baseline characteristics of both groups are presented in
Table 1. Briefly, the average age of participants was 35 years, and
approximately half were women. All participants were healthy,
and few smoked. Although we attempted to recruit subjects in
equal proportions across three BMI strata, the average BMI was
slightly higher among white Caucasians compared to South Asians
(28.6 vs 26.6 kg/m
2,P ,0.05), chiefly due to difficulties in finding
healthy South Asians with high BMI and white Caucasians with
low BMI. Due to these differences in body size, we adjusted all
ethnic comparisons for age, sex and BMI.
Metabolic Risk Factors
South Asians compared to white Caucasians had increased
insulin (mean difference (md): 0.44; 95% CI: 0.20–0.69 in ln fasting
insulin), lower HDL cholesterol (md: 20.13; 95% CI:20.26 to
20.01) and lower adiponectin (md: 22.38; 95% CI: 23.59 to
21.17). No differences in fasting glucose, LDL cholesterol, blood
pressure, or hs-CRP were observed. (Table 1)
Adipose Tissue Amount, Distribution, and Cell Analysis
Body fat percentage as determined by DXA scan was higher
among South Asians compared to white Caucasians (md: 2.69;
95% CI: 0.70 to 4.69). The waist to hip ratio (md: 0.03; 95% CI:
0.01–0.05) was increased among South Asians compared to white
Caucasians. Abdominal fat distribution as determined by MRI
indicated that South Asians had less superficial subcutaneous
tissue, as a percentage of their total abdominal fat, compared to
the white Caucasians (md difference: 22.94; 95% CI: 25.56
to20.32), and South Asians had relatively more deep subcutane-
ous and visceral fat compared to superficial subcutaneous fat (md
in ratio: 0.34; 95% CI:0.02 to0.65). Fat infiltration of the liver was
substantially higher among South Asians compared to white
Caucasians (md: 7.43%; 95% CI: 2.30 to 12.55).(Table 2) Further,
the area of adipocytes was significantly greater among South
Asians compared to white Caucasians (md: 64.2; 95% CI: 24.3 to
104.1), as was the maximum adipocyte diameter (md: 20.68; 95%
CI: 7.86–33.5). (Table 2)
Muscle Tissue Characteristics
Using DXA scan, South Asians had significantly lower lean
body mass compared to white Caucasians (md: 23.25; 95% CI:
25.35 to 21.14).(Table 2) Skeletal muscle biopsy specimens were
analyzed for intramyocellular lipid content (IMCL) and no
differences in the area density of total, sub-sarcolemmal and
intramyofibrillar IMCL were observed between the groups, even
after adjustment for the fitness level of each subject (VO2 max).
(Table 2)
Influence of Adipose Tissue Characteristics on Ethnic
Differences in Insulin, Lipids and Adiponectin
Ethnic differences in fasting insulin, HDL cholesterol and
adiponectin were not altered after adjustment for body fat
distribution (waist to hip ratio, percentage body fat or deep/
visceral to superficial fat ratio) but were attenuated after
adjustment for adipocyte area. (Figure 1)
Liver Fat Infiltration
The presence of fat infiltration in the liver was associated with
significant changes in metabolic risk factors. (Table 3) Individuals
classified in the highest tertile of liver fat infiltration were older,
more likely to be male, South Asian, and to have a higher BMI
(P=0.0002). Fasting insulin (P=0.009), fasting triglycerides
(P=0.03), and adipocyte size (P=0.02), remained significantly
associated with increasing liver fat infiltration after adjustment for
age, sex, and BMI. (Table 3) To test the adipose tissue overflow
hypothesis [6], we adjusted the ethnic difference in liver fat
infiltration for differences in adipocyte area and additionally for
the relative amount of abdominal deep/visceral to superficial
Figure 1. BMI: Body Mass Index, error bars represent the
standard error.
doi:10.1371/journal.pone.0022112.g001
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ethnic difference in liver fat infiltration (7.2% +/22.0 vs 4.0% +/
22.0; P=0.30). (Figure 2)
Discussion
We observed differences in cardiovascular risk factors and
ectopic fat deposition in South Asians compared to white
Caucasians which can be explained by increased adipocyte size.
This supports the hypothesis that South Asians have a lower
capacity to store fat in subcutaneous adipocytes than white
Caucasians. Excess fat, therefore, ‘‘overflows’’ to ectopic compart-
ments, in the abdomen and liver [6]. (Figure 3)
Adipose tissue mass expansion occurs by the expansion of pre-
existing adipocytes (adipocyte hypertrophy) or by generating new
small adipocytes (hyperplasia), or both [17]. Adipocyte hypertro-
phy usually develops secondary to chronic overfeeding and is
associated with metabolic abnormalities including reduced adipo-
nectin, lipolysis from fat cells and increased insulin production
[18–22]. Altered adipocyte function and storage is also seen in
people with congenital and acquired lipodystrophy, as the
adipocytes are unable to store triglycerides and high concentra-
tions of fatty acids are shunted to the liver resulting in insulin
resistance and dyslipidemia [23]. Our observations are consistent
with an ‘‘ethnic lipodystrophy’’ as South Asians have a
preponderance of adipocyte hypertrophy, lower adiponectin,
reduced superficial subcutaneous fat, increased secondary storage
in deep and visceral fat, and higher levels of ectopic fat deposition
in the liver compared to people of European origin. This excess
delivery of fatty acids to the liver causes fat deposition in the
hepatocytes which results in increased hepatic gluconeogenesis,
hepatic insulin resistance, and increased production of triglycer-
ides which enter the systemic circulation [24]. Our results are
consistent with prior observations in which South Asians
compared to white Caucasians were observed to have an excess
of fatty liver infiltration and insulin resistance [25]. However our
results are only partially congruent with others findings that
despite South Asians having an increased adipocyte size in the
superficial subcutaneous adipose depot and lower adiponectin,
they had greater subcutaneous abdominal fat mass and lower visceral
fat mass as measured by MRI [26]. This difference may be
attributed to the differences in study subjects as only young men
with a relatively low average BMI of 24 were included. In fact
when we restrict our data to match these criteria (South Asian
Table 3. Risk factor profile by liver fat tertiles.
Liver fat tertile group: Mean (SE)
Tertile 1 Tertile 2 Tertile 3 P-value* P-value**
Number/Group 31 32 32
South Asian: N (%) 11 (35.5) 19 (59.4) 22 (68.8)
Age (years) 31.77 (1.81) 36.94 (1.66) 40.34 (1.30)
Body Mass Index (kg/m
2) 24.60 (0.72) 27.07 (0.86) 30.59 (0.87) 0.0002
Waist to Hip Ratio 0.82 (0.01) 0.87 (0.01) 0.93 (0.01) 0.002 0.06
Body Fat (%) 30.19 (2.18) 34.32 (1.90) 36.60 (1.61) 0.0002 0.16
Visceral Fat area (cm
2) 66.57 (5.46) 124.94 (13.09) 169.15 (14.48) 0.0018 0.37
Subcutaneous Fat area (cm
2) 205.51 (21.87) 247.89 (19.24) 319.68 (22.87) 0.001 0.63
Adipocyte Area (x100 units
2) 365.85 (16.30) 419.53 (18.98) 480.78 (18.01) 0.0009 0.02
Adipocyte Diameter (units) 231.68 (5.58) 248.08 (6.46) 268.18 (5.32) 0.002 0.04
Fasting Glucose (mmol/L) 4.72 (0.07) 5.07 (0.10) 5.27 (0.09) 0.02 0.10
Fasting Insulin - LN (pmol/L) 3.55 (0.11) 4.17 (0.15) 4.48 (0.10) 0.0001 0.009
Fasting Triglycerides (mmol/L) 0.90 (0.08) 1.37 (0.17) 2.03 (0.22) 0.002 0.03
Fasting HDL (mmol/L) 1.41 (0.05) 1.36 (0.06) 1.15 (0.06) 0.03 0.22
hs-CRP (mg/L) 1.51 (0.31) 1.73 (0.28) 3.30 (0.93) 0.02 0.65
Diastolic BP (mm/Hg) 71.42 (1.41) 73.25 (1.30) 79.28 (1.52) 0.06 0.21
Adiponectin (ug/mL) 8.42 (0.70) 6.06 (0.60) 4.63 (0.55) 0.03 0.08
* Adjusted for age and sex.
** Adjusted for age, sex and BMI.
doi:10.1371/journal.pone.0022112.t003
Figure 2. BMI: Body Mass Index, error bars represent the
standard error.
doi:10.1371/journal.pone.0022112.g002
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visceral fat area compared to their white Caucasian counterparts.
Thus, understanding the differences in fat distribution between
South Asians and white Caucasians may require inclusion of men
and women across wide ranges of BMI as distributional differences
may only become apparent when studying overweight and obese
individuals.
South Asians have lower lean body mass compared to white
Caucasians. We did not observe ethnic variations in IMCL
content. IMCL can be influenced by peak exercise capacity [27]
and therefore we carefully assessed differences in maximal aerobic
capacity and muscle strength and it was not associated with
adipocyte size, visceral fat area, adiponectin level, liver fat
infiltration, or insulin resistance. These results differ from the
observations of two smaller studies conducted in young South
Asian men. The first reported that young South Asian men have
increased deposition of IMCL compared to Europeans, although
no association with IMCL and insulin sensitivity was observed
[28]. The second reported an increased IMCL among South
Asian men compared to white Caucasian men [25]. Our
observations may differ from these studies because we included a
larger number of subjects across a wider range of BMI, and
because half of our subjects are women. Furthermore, neither of
the two previous studies adjusted the IMCL for aerobic capacity or
muscle strength. Our findings are consistent with prior observa-
tions among young normoglycemic PIMA Indians and other
ethnic groups [29] and strongly suggest that IMCL does not
account for the marked ethnic difference in metabolic abnormal-
ities we observed between South Asians and white Caucasians.
Metabolic Markers
We observed that young healthy South Asians have significantly
lower levels of adiponectin compared to their white Caucasian
counterparts. Low levels of adiponectin are associated with
reduced insulin sensitivity, and previous South Asian-white
Caucasian comparisons have reported that South Asians have a
reduced concentration of adiponectin [30]. On the other hand
white Caucasians appear to be relatively protected from reduced
adiponectin until they reach very high BMIs i.e. $35 [31].
Adiponectin is produced from subcutaneous and visceral adipo-
cytes and the exact proportion of circulating adiponectin
attributed to each depot is debated [32,33]. There is recent
evidence demonstrating that adipocyte dysfunction is caused by
cellular hypoxia of adipocytes secondary to adipocyte hypertrophy
which results in lowered adiponectin synthesis [34]. Large
adipocytes are characterized by a reduced production and
secretion of adiponectin compared with small newly differentiated
adipocytes. In our study the ‘‘ethnic difference’’ in adiponectin was
attenuated after adjustment for adipocyte area, which suggests that
adipocyte hypertrophy has a significant influence on this
biomarker. Thus, our data which draws a strong association
between subcutaneous adipocyte hypertrophy and low adiponectin
suggest that adipocyte hypertrophy is an important pathophysio-
logic step in the overflow of fatty acids from subcutaneous fat to
deep visceral fat, to liver fat which is marked by lowered
adiponectin. The clinical relevance of our findings are therefore,
that the presence of abdominal obesity and/or cardio-metabolic
risk factors including elevated insulin, low HDL, or low
adiponectin in South Asian patients should prompt clinicians to
Figure 3. HDL: High Density Lipoprotein, CRP: C-reactive protein.
doi:10.1371/journal.pone.0022112.g003
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health behaviour changes and/or medical therapy to try and
normalize their risk factor profile.
There are a number of implications of our study. First, young,
apparently healthy South Asians have greater metabolic impair-
ment compared to white Caucasians who tend to develop
metabolic changes at higher levels of obesity and at a more
advanced age. Our data helps to explain why South Asians suffer
an excess burden of type 2 diabetes and coronary heart disease
compared with white Caucasians [35], and supports earlier
screening for abdominal adiposity and elevated glucose among
South Asians. Second, the metabolic changes observed in South
Asians may be prevented by avoiding chronic over nutrition,
thereby preventing its consequences (including adipocyte hyper-
trophy, abdominal adiposity, and ectopic fat deposition). Third,
adipocyte cell area and metabolic risk factors may be reduced by
reduction of daily energy intake, increased energy expenditure, or
by shifting fat deposition from ectopic sites to subcutaneous depots
using pharmacologic agents (i.e. PPAR gamma agonists). The
limitations of our study include its cross-sectional design, which
precludes determination of the temporal nature of the associations
between chronic over nutrition, adipocyte hypertrophy, ectopic fat
deposition, and metabolic changes, and its relatively small size.
However, we assembled a relatively healthy population across a
wide range of BMI excluding those with established CVD or type
2 diabetes in order to minimize the effect of medications, dietary
changes, or advanced disease pathophysiology. Furthermore, we
observed some intriguing ethnic differences by sex, most notably
South Asian women’s propensity toward liver fat infiltration
compared to white Caucasian women. However, the small sample
size precluded any detailed study of interactions by sex. Ideally our
findings should be reproduced in larger prospective studies to
assess if adipocyte hypertrophy is a significant predictor of the
incident development of fatty liver infiltration and type 2 diabetes,
as well as in randomized trials in which interventions which reduce
adipocyte hypertrophy or ecoptic fat deposition are tested. Finally,
we did not collect information on whether South Asians were first
or second generation immigrants to Canada. This may have
introduced heterogeneity in our findings as the time since
immigration to Canada influences diabetes risk [36]. However,
most studies of South Asian immigrants have reported that the
propensity to develop insulin resistance and greater adiposity exists
regardless of the first or second generation immigrant status [37].
Summary
South Asians have an increased adipocyte area compared to
white Caucasians. This difference accounts for the ethnic
differences in insulin, HDL cholesterol, adiponectin, and the
ectopic fat deposition in the liver. Interventions which reduce
adipocyte area may improve the metabolic profile of South Asians.
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